Blackstone Inc’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Blackstone Inc’s Portfolio LYRA Stock Details LYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-500	Closed	-$284K	–	191
2020 Q2	$284K	Buy	+500	New	+$366K	﹤0.01%	144

Other funds holding LYRA

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Blackstone Inc's LYRA Position: Q3 2020 in Review

Blackstone Inc sold out of LYRA THERAPEUTICS INC (LYRA) in Q3 2020, closing a stake of 500 shares — an estimated $284K sold.

Blackstone Inc first reported a position in LYRA in Q2 2020 and held it in 1 quarter. The position peaked at $284K in Q2 2020. 40 funds tracked by Wall St. Rank hold LYRA as of Q3 2020.

Blackstone Inc reported no remaining LYRA THERAPEUTICS INC position as of Q3 2020 after selling out during the quarter.
Blackstone Inc sold 500 LYRA THERAPEUTICS INC shares in Q3 2020, an estimated $284K.
Blackstone Inc first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 1 quarter.
Blackstone Inc's LYRA THERAPEUTICS INC position peaked at $284K in Q2 2020.
40 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q3 2020.

Based on Blackstone Inc's 13F filing for Q3 2020, filed 16 Nov 2020.